Calmare Therapeutics Inc CTTC Stock Analysis
- OTCCE
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Jul 14
Last close · Previous close $0.00
- Market cap
- At the Jul 14 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- Last 12 months
Price chart
$0.00unchangedFri, Jul 14 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Jul 13
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Valuation
Financials
Dividends
About Calmare Therapeutics Inc
Competitive Technologies, Inc. (CTTC) provides distribution, patent and technology transfer, sales and licensing services focusing on the needs of its customers. CTTC develops relationships with universities, companies, inventors and patent or intellectual property holders to obtain the rights or a license to their intellectual property (technologies) or to their product. The Company also develops relationships with those who have a need or uses for technologies or products. During the year ended December 31, 2011, the Company earned revenue in two ways: retained royalties from licensing its clients' and its own technologies to its customer licensees, and sales of finished products. CTTC is the obligor, responsible for delivering devices, as well as for training its customers to use the device. The Company deals directly with customers, setting pricing and providing training.
- Sector
- Industry
- Headquarters
- Exchange
- OTCCE
- Asset type
- Common stock
- Price history since
CTTC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
CTTC stock FAQ
What is CTTC stock’s price today?
Calmare Therapeutics (CTTC) traded at $0.00 at the close on , unchanged from the previous close of $0.00.
What exchange does CTTC trade on?
Calmare Therapeutics trades on the OTCCE under the ticker symbol CTTC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.








